Marcie J. Hursting

4.5k total citations · 1 hit paper
74 papers, 3.3k citations indexed

About

Marcie J. Hursting is a scholar working on Surgery, Internal Medicine and Hematology. According to data from OpenAlex, Marcie J. Hursting has authored 74 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Surgery, 49 papers in Internal Medicine and 30 papers in Hematology. Recurrent topics in Marcie J. Hursting's work include Heparin-Induced Thrombocytopenia and Thrombosis (65 papers), Venous Thromboembolism Diagnosis and Management (49 papers) and Platelet Disorders and Treatments (22 papers). Marcie J. Hursting is often cited by papers focused on Heparin-Induced Thrombocytopenia and Thrombosis (65 papers), Venous Thromboembolism Diagnosis and Management (49 papers) and Platelet Disorders and Treatments (22 papers). Marcie J. Hursting collaborates with scholars based in United States, Canada and Qatar. Marcie J. Hursting's co-authors include Suzanne K. Swan, Ik–Kyung Jang, Bruce Lewis, Stephen D. Hursting, William Matthai, John R. Bartholomew, David McCollum, Robert L. Levine, Diane E. Wallis and Philip M. Brown and has published in prestigious journals such as Circulation, Blood and Stroke.

In The Last Decade

Marcie J. Hursting

74 papers receiving 3.1k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia

2001 507 citations Bruce Lewis, Diane E. Wallis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marcie J. Hursting United States	30	2.5k	2.0k	1.2k	969	828	74	3.3k
Laurent Bonello France	34	2.1k 0.8×	904 0.5×	264 0.2×	3.6k 3.7×	265 0.3×	187	4.6k
Annick Ankri France	26	703 0.3×	758 0.4×	120 0.1×	1.2k 1.2×	576 0.7×	67	2.5k
Dimitrios A. Tsakiris Switzerland	24	511 0.2×	530 0.3×	144 0.1×	501 0.5×	384 0.5×	81	1.6k
Piergiovanni Buonamici Italy	26	2.0k 0.8×	585 0.3×	136 0.1×	3.6k 3.7×	133 0.2×	54	4.0k
Angela Migliorini Italy	30	2.7k 1.1×	685 0.3×	144 0.1×	4.0k 4.2×	97 0.1×	134	4.6k
De Backer G United Kingdom	3	711 0.3×	313 0.2×	176 0.2×	1.6k 1.7×	139 0.2×	12	2.2k
Peter Nicol Sweden	12	586 0.2×	1.4k 0.7×	52 0.0×	1.5k 1.6×	617 0.7×	17	2.7k
Edward Genton United States	28	714 0.3×	1.3k 0.7×	70 0.1×	1.7k 1.8×	679 0.8×	87	3.0k
David J. Moliterno United States	32	1.1k 0.5×	630 0.3×	36 0.0×	2.5k 2.6×	365 0.4×	100	3.4k
Russell J. Ivanhoe United States	12	1.4k 0.5×	148 0.1×	168 0.1×	2.5k 2.6×	161 0.2×	19	3.3k

Countries citing papers authored by Marcie J. Hursting

Since Specialization

Citations

This map shows the geographic impact of Marcie J. Hursting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcie J. Hursting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcie J. Hursting more than expected).

Fields of papers citing papers by Marcie J. Hursting

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcie J. Hursting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcie J. Hursting. The network helps show where Marcie J. Hursting may publish in the future.

Co-authorship network of co-authors of Marcie J. Hursting

This figure shows the co-authorship network connecting the top 25 collaborators of Marcie J. Hursting. A scholar is included among the top collaborators of Marcie J. Hursting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcie J. Hursting. Marcie J. Hursting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hursting, Stephen D., Sarah M. Dunlap, Nikki A. Ford, Marcie J. Hursting, & Laura M. Lashinger. (2013). Calorie restriction and cancer prevention: a mechanistic perspective. Cancer & Metabolism. 1(1). 10–10. 100 indexed citations

Sniecinski, Roman M., Marcie J. Hursting, Michael J. Paidas, & Jerrold H. Levy. (2010). Etiology and Assessment of Hypercoagulability with Lessons from Heparin-Induced Thrombocytopenia. Anesthesia & Analgesia. 112(1). 46–58. 6 indexed citations

Hursting, Marcie J. & Patrick Murray. (2008). Argatroban Anticoagulation in Renal Dysfunction: A Literature Analysis. Nephron Clinical Practice. 109(2). c80–c94. 34 indexed citations

Rice, Lawrence, Marcie J. Hursting, G. Mark Baillie, & David McCollum. (2007). Argatroban Anticoagulation in Obese Versus Nonobese Patients: Implications for Treating Heparin‐induced Thrombocytopenia. The Journal of Clinical Pharmacology. 47(8). 1028–1034. 21 indexed citations

Hursting, Marcie J. & Ik–Kyung Jang. (2007). Effect of body mass index on Argatroban therapy during percutaneous coronary intervention. Journal of Thrombosis and Thrombolysis. 25(3). 273–279. 11 indexed citations

Francis, John L., et al.. (2007). Heparin–platelet factor 4 antibodies in patients presenting to the ED with thrombosis. The American Journal of Emergency Medicine. 25(3). 279–284. 4 indexed citations

Levy, Jerrold H. & Marcie J. Hursting. (2007). Heparin-induced Thrombocytopenia, a Prothrombotic Disease. Hematology/Oncology Clinics of North America. 21(1). 65–88. 24 indexed citations

Lewis, Bruce, Diane E. Wallis, & Marcie J. Hursting. (2006). Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risk in heparin-induced thrombocytopenia. Journal of Vascular Surgery. 44(5). 1132–1132. 1 indexed citations

Lewis, Bruce, Diane E. Wallis, Marcie J. Hursting, Robert L. Levine, & Fred Leya. (2006). Effects of Argatroban Therapy, Demographic Variables, and Platelet Count on Thrombotic Risks in Heparin-Induced Thrombocytopenia. CHEST Journal. 129(6). 1407–1416. 82 indexed citations

10.

Murray, Patrick & Marcie J. Hursting. (2006). Heparin-Induced Thrombocytopenia in Patients Administered Heparin Solely for Hemodialysis. Renal Failure. 28(7). 537–539. 16 indexed citations

11.

Levine, Robert L., David McCollum, & Marcie J. Hursting. (2006). How Frequently Is Venous Thromboembolism in Heparin-Treated Patients Associated With Heparin-Induced Thrombocytopenia?. CHEST Journal. 130(3). 681–687. 21 indexed citations

12.

Guzzi, Louis M., David McCollum, & Marcie J. Hursting. (2006). Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia. Journal of Thrombosis and Thrombolysis. 22(3). 169–176. 35 indexed citations

13.

Patterson, Shawnna L., Marian P. LaMonte, Jamal Mikdashi, Stuart T. Haines, & Marcie J. Hursting. (2006). Anticoagulation Strategies for Treatment of Ischemic Stroke and Antiphospholipid Syndrome: Case Report and Review of the Literature. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(10). 1518–1525. 5 indexed citations

14.

LaMonte, Marian P., Philip M. Brown, & Marcie J. Hursting. (2005). Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitor. Expert Review of Cardiovascular Therapy. 3(1). 31–41. 17 indexed citations

15.

Matthai, William, Marcie J. Hursting, Bruce Lewis, & John G. Kelton. (2004). Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia. Thrombosis Research. 116(2). 121–126. 36 indexed citations

16.

Hursting, Marcie J., et al.. (2003). Argatroban Dosing in Patients with Heparin-Induced Thrombocytopenia. Annals of Pharmacotherapy. 37(7-8). 970–975. 27 indexed citations

17.

Peter, John V. St., et al.. (2000). Comparison of Anticoagulant Effects and Safety of Argatroban and Heparin in Healthy Subjects. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(7). 756–770. 75 indexed citations

18.

Schwarz, Richard P., et al.. (1997). State-of-the-Art Review: The Preclinical and Clinical Pharmacology of Novastan (Argatroban): A Small-Molecule, Direct Thrombin Inhibitor. Clinical and Applied Thrombosis/Hemostasis. 3(1). 1–15. 19 indexed citations

19.

Hursting, Marcie J., et al.. (1993). Effects of age, race, sex, and smoking on prothrombin fragment 1.2 in a healthy population. Clinical Chemistry. 39(4). 683–686. 37 indexed citations

20.

Hursting, Marcie J., Kent E. Opheim, Vidmantas A. Raisys, Margaret A. Kenny, & Gregory J. Metzger. (1989). Tricyclic Antidepressant-Specific fab fragments alter the distribution and elimination of desipramine in the rabbit: A Model for overdose treatment. Journal of Toxicology Clinical Toxicology. 27(1-2). 53–66. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact